UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2010
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 001-12019
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)
Pennsylvania | 23-0993790 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
One Quaker Park, 901 E. Hector Street, Conshohocken, Pennsylvania |
19428 2380 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: 610-832-4000
Not Applicable
Former name, former address and former fiscal year, if changed since last report.
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ¨ | Accelerated filer | x | |||
Non-accelerated filer | ¨ (Do not check if smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
Number of Shares of Common Stock Outstanding on September 30, 2010 |
11,376,232 |
QUAKER CHEMICAL CORPORATION AND CONSOLIDATED SUBSIDIARIES
* * * * * * * * * *
2
FINANCIAL INFORMATION
Item 1. | Financial Statements (Unaudited). |
Condensed Consolidated Balance Sheet
Unaudited (Dollars in thousands, except par value and share amounts) |
||||||||
September 30, 2010 |
December 31, 2009* |
|||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | 27,149 | $ | 25,051 | ||||
Construction fund (restricted cash) |
| 2,358 | ||||||
Accounts receivable, net |
117,238 | 108,793 | ||||||
Inventories |
||||||||
Raw materials and supplies |
30,437 | 23,495 | ||||||
Work-in-process and finished goods |
28,370 | 26,545 | ||||||
Prepaid expenses and other current assets |
13,831 | 12,656 | ||||||
Total current assets |
217,025 | 198,898 | ||||||
Property, plant and equipment, at cost |
193,188 | 190,980 | ||||||
Less accumulated depreciation |
(127,602 | ) | (123,554 | ) | ||||
Net property, plant and equipment |
65,586 | 67,426 | ||||||
Goodwill |
49,493 | 46,515 | ||||||
Other intangible assets, net |
7,175 | 5,579 | ||||||
Investments in associated companies |
9,995 | 8,824 | ||||||
Deferred income taxes |
31,953 | 31,692 | ||||||
Other assets |
47,288 | 39,537 | ||||||
Total assets |
$ | 428,515 | $ | 398,471 | ||||
LIABILITIES AND EQUITY |
||||||||
Current liabilities |
||||||||
Short-term borrowings and current portion of long-term debt |
$ | 939 | $ | 2,431 | ||||
Accounts and other payables |
59,854 | 60,939 | ||||||
Accrued compensation |
16,939 | 16,656 | ||||||
Accrued pension and postretirement benefits |
1,628 | 4,717 | ||||||
Other current liabilities |
19,865 | 15,224 | ||||||
Total current liabilities |
99,225 | 99,967 | ||||||
Long-term debt |
58,445 | 63,685 | ||||||
Deferred income taxes |
9,268 | 8,605 | ||||||
Accrued pension and postretirement benefits |
26,678 | 27,602 | ||||||
Other non-current liabilities |
48,477 | 42,317 | ||||||
Total liabilities |
242,093 | 242,176 | ||||||
Equity |
||||||||
Common stock $1 par value; authorized 30,000,000 shares; issued 2010 11,376,232; 2009 11,085,549 shares |
11,376 | 11,086 | ||||||
Capital in excess of par value |
35,731 | 27,527 | ||||||
Retained earnings |
140,161 | 123,140 | ||||||
Accumulated other comprehensive loss |
(7,919 | ) | (10,439 | ) | ||||
Total Quaker shareholders equity |
179,349 | 151,314 | ||||||
Noncontrolling interest |
7,073 | 4,981 | ||||||
Total equity |
186,422 | 156,295 | ||||||
Total liabilities and equity |
$ | 428,515 | $ | 398,471 | ||||
* | Condensed from audited financial statements |
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
Condensed Consolidated Statement of Income
Unaudited (Dollars in thousands, except per share amounts) |
||||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Net sales |
$ | 137,669 | $ | 118,922 | $ | 401,980 | $ | 319,764 | ||||||||
Cost of goods sold |
88,641 | 74,450 | 257,081 | 210,541 | ||||||||||||
Gross profit |
49,028 | 44,472 | 144,899 | 109,223 | ||||||||||||
Selling, general and administrative expenses |
34,699 | 34,646 | 103,486 | 90,393 | ||||||||||||
Contingencies charge (See Note 15 Commitments and Contingencies) |
3,581 | | 3,581 | | ||||||||||||
CEO transition costs |
1,317 | 1,250 | 1,317 | 2,443 | ||||||||||||
Restructuring and related activities |
| | | 2,289 | ||||||||||||
Operating income |
9,431 | 8,576 | 36,515 | 14,098 | ||||||||||||
Other (expense) income, net |
(320 | ) | 217 | 1,566 | 2,027 | |||||||||||
Interest expense |
(1,345 | ) | (1,356 | ) | (4,042 | ) | (4,136 | ) | ||||||||
Interest income |
313 | 178 | 840 | 551 | ||||||||||||
Income before taxes and equity in net income of associated companies |
8,079 | 7,615 | 34,879 | 12,540 | ||||||||||||
Taxes on income before equity in net income of associated companies |
1,661 | 2,747 | 8,985 | 4,063 | ||||||||||||
Income before equity in net income of associated companies |
6,418 | 4,868 | 25,894 | 8,477 | ||||||||||||
Equity in net income of associated companies |
439 | 555 | 734 | 640 | ||||||||||||
Net income |
6,857 | 5,423 | 26,628 | 9,117 | ||||||||||||
Less: Net income attributable to noncontrolling interest |
517 | 371 | 1,716 | 829 | ||||||||||||
Net income attributable to Quaker Chemical Corporation |
$ | 6,340 | $ | 5,052 | $ | 24,912 | $ | 8,288 | ||||||||
Per share data: |
||||||||||||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders basic |
$ | 0.56 | $ | 0.46 | $ | 2.22 | $ | 0.76 | ||||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders diluted |
$ | 0.55 | $ | 0.45 | $ | 2.19 | $ | 0.75 | ||||||||
Dividends declared |
$ | 0.235 | $ | 0.23 | $ | 0.70 | $ | 0.69 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
Condensed Consolidated Statement of Cash Flows
Unaudited (Dollars in thousands) |
||||||||
For the Nine Months Ended September 30, |
||||||||
2010 | 2009 | |||||||
Cash flows from operating activities |
||||||||
Net income |
$ | 26,628 | $ | 9,117 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation |
7,448 | 6,948 | ||||||
Amortization |
736 | 797 | ||||||
Equity in undistributed earnings of associated companies, net of dividends |
(523 | ) | (610 | ) | ||||
Deferred compensation and other, net |
1,559 | (30 | ) | |||||
Stock-based compensation |
2,371 | 1,585 | ||||||
Restructuring and related activities |
| 2,289 | ||||||
Gain on disposal of property, plant and equipment |
(24 | ) | (1,194 | ) | ||||
Insurance settlement realized |
(1,225 | ) | (1,104 | ) | ||||
Pension and other postretirement benefits |
(3,184 | ) | (5,877 | ) | ||||
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions: |
||||||||
Accounts receivable |
(7,982 | ) | 951 | |||||
Inventories |
(8,645 | ) | 12,547 | |||||
Prepaid expenses and other current assets |
(2,656 | ) | 3,283 | |||||
Accounts payable and accrued liabilities |
5,007 | 10,273 | ||||||
Change in restructuring liabilities |
| (4,240 | ) | |||||
Net cash provided by operating activities |
19,510 | 34,735 | ||||||
Cash flows from investing activities |
||||||||
Investments in property, plant and equipment |
(6,259 | ) | (9,811 | ) | ||||
Payments related to acquisitions |
(6,862 | ) | (1,000 | ) | ||||
Proceeds from disposition of assets |
147 | 1,640 | ||||||
Insurance settlement received and interest earned |
5,099 | 5,164 | ||||||
Change in restricted cash, net |
(1,516 | ) | 416 | |||||
Net cash used in investing activities |
(9,391 | ) | (3,591 | ) | ||||
Cash flows from financing activities |
||||||||
Net decrease in short-term borrowings |
(1,394 | ) | (1,796 | ) | ||||
Proceeds from long-term debt |
29 | 3,500 | ||||||
Repayments of long-term debt |
(5,367 | ) | (22,875 | ) | ||||
Dividends paid |
(7,768 | ) | (7,565 | ) | ||||
Stock options exercised, other |
3,829 | 353 | ||||||
Excess tax benefit related to stock option exercises |
2,294 | | ||||||
Distributions to noncontrolling shareholders |
| (274 | ) | |||||
Net cash used in financing activities |
(8,377 | ) | (28,657 | ) | ||||
Effect of exchange rate changes on cash |
356 | 1,990 | ||||||
Net increase in cash and cash equivalents |
2,098 | 4,477 | ||||||
Cash and cash equivalents at beginning of period |
25,051 | 20,892 | ||||||
Cash and cash equivalents at end of period |
$ | 27,149 | $ | 25,369 | ||||
Supplemental cash flow disclosures: |
||||||||
Non-cash activities: |
||||||||
Restricted insurance receivable (See also Note 15 of Notes to Condensed Consolidated Financial Statements) |
5,000 | 5,000 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands, except per share amounts)
(Unaudited)
Note 1 Condensed Consolidated Financial Information
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States for interim financial reporting and the United States Securities and Exchange Commission regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. Certain reclassifications of prior years data have been made to improve comparability. The results for the three and nine months ended September 30, 2010 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Companys Annual Report filed on Form 10-K for the year ended December 31, 2009.
Included in the third quarter 2010 results is a net charge of $3,581 or approximately $0.21 per diluted share, related to a non-income tax contingency. Refer to Note 15 Commitments and Contingencies for further discussion of this matter.
The Company has been recognizing certain accelerated and other costs in accordance with the retirement of the Companys former CEO. The Company incurred a final charge of $1,317 during the third quarter of 2010 related to the former CEOs supplemental retirement income plan.
Effective January 1, 2010, the Venezuelan economy was considered to be hyperinflationary under generally accepted accounting principles in the United States, since it has experienced a rate of general inflation in excess of 100% over the latest three-year period, based upon the blended Consumer Price Index and National Consumer Price Index. Accordingly, all gains and losses resulting from the remeasurement of the Companys Venezuelan 50% equity affiliate (Kelko Quaker Chemical, S.A.) are required to be recorded directly in the statement of operations. On January 8, 2010, the Venezuelan government announced the devaluation of the Bolivar Fuerte and the establishment of a two-tiered exchange structure. As a result of the devaluation, the Company recorded a charge of approximately $0.03 per diluted share in the first quarter of 2010.
As part of the Companys chemical management services, certain third-party product sales to customers are managed by the Company. Where the Company acts as principal, revenues are recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as an agent, such revenue is recorded using net reporting as service revenues at the amount of the administrative fee earned by the Company for ordering the goods. Third-party products transferred under arrangements resulting in net reporting totaled $42,560 and $16,598 for the nine months ended September 30, 2010 and 2009, respectively.
Note 2 Recently Issued Accounting Standards
The FASB updated its guidance regarding a vendors multiple-deliverable arrangements in October 2009. The updated guidance establishes a selling price hierarchy to be followed in determining the selling price for each deliverable in multiple-deliverable arrangements, eliminates the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement using the relative selling price method and requires enhanced disclosure regarding multiple-deliverable arrangements. The guidance is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning after June 15, 2010. The Company is currently assessing the impact of this guidance on its financial statements.
Note 3 Restructuring and Related Activities
In the first quarter of 2009, Quakers management implemented a restructuring program totaling $2,289. The Company completed the initiatives under this program during 2009.
Note 4 Income Taxes and Uncertain Income Tax Positions
The Companys year-to-date 2010 effective tax rate of 25.8% includes a benefit of approximately $0.15 per diluted share due to the expiration of applicable statutes of limitations for uncertain tax positions. In addition, the effective tax rate reflects increased utilization of foreign tax credits and net operating losses, which were previously not benefited. The effective tax rate for the first nine months of 2009 reflects no tax provided for the gain on the disposition of land in Europe, due the utilization of net operating losses, which were previously not benefited.
The FASBs guidance regarding accounting for uncertainty in income taxes prescribes the recognition threshold and measurement attributes for financial statement recognition and measurement of tax positions taken or expected to be taken on a tax return. The
6
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
guidance further requires the determination of whether the benefits of tax positions will be more likely than not sustained upon audit based upon the technical merits of the tax position. For tax positions that are determined to be more likely than not sustained upon audit, a company recognizes the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement in the financial statements. For tax positions that are not determined to be more likely than not sustained upon audit, a company does not recognize any portion of the benefit in the financial statements. Additionally, the guidance provides for derecognition, classification, penalties and interest, accounting in interim periods, disclosure and transition.
At December 31, 2009, the Companys cumulative liability for gross unrecognized tax benefits was $10,686. As of September 30, 2010, the Companys cumulative liability for gross unrecognized tax benefits was $10,672.
The Company continues to recognize interest and penalties associated with uncertain tax positions as a component of taxes on income in its Consolidated Statement of Income. The Company had accrued $1,850 for cumulative interest and $911 for cumulative penalties at December 31, 2009. The Company has recognized $29 and $112 for interest and $17 and $197 for penalties on its Consolidated Statement of Income for the three-month and nine-month periods ended September 30, 2010, respectively, and as of September 30, 2010, the Company had accrued $1,894 for cumulative interest and $1,084 for cumulative penalties.
During the three and nine-month periods ended September 30, 2010, the Company derecognized several uncertain tax positions due to expiration of the applicable statutes of limitations for certain tax years of approximately $447 and $1,370, respectively.
The Company estimates that for the full year ended December 31, 2010 it will reduce its cumulative liability for gross unrecognized tax benefits by approximately $1,800 to $1,900 due to the expiration of the statute of limitations with regard to certain tax positions. This estimated reduction in the cumulative liability for unrecognized tax benefits does not consider any increase in liability for unrecognized tax benefits with regard to existing tax positions or any increase in cumulative liability for unrecognized tax benefits with regard to new tax positions for the year ended December 31, 2010.
The Company and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various state and foreign tax jurisdictions. Tax years that remain subject to examination by major tax jurisdictions include the Netherlands and United Kingdom from 2004, Italy, Brazil and China from 2005, Spain from 2006, United States from 2007, France from 2008, and various domestic state tax jurisdictions from 1993.
Note 5 Fair Value Measurements
The FASBs guidance regarding fair value measurements establishes a common definition for fair value to be applied to guidance requiring use of fair value, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements. The guidance does not require any new fair value measurements, but rather applies to all other accounting guidance that requires or permits fair value measurements.
The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
| Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. |
| Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. |
| Level 3: Unobservable inputs that reflect the reporting entitys own assumptions. |
The Company values its interest rate swaps, company-owned life insurance policies and various deferred compensation assets and liabilities at fair value. The Companys assets and liabilities subject to fair value measurement are as follows (in thousands):
7
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
Fair Value as of September 30, 2010 |
Fair Value Measurements at September 30, 2010 Using Fair Value Hierarchy |
|||||||||||||||
Level 1 | Level 2 | Level 3 | ||||||||||||||
Assets |
||||||||||||||||
Company-owned life insurance |
$ | 1,950 | $ | | $ | 1,950 | $ | | ||||||||
Company-owned life insurance - Deferred compensation assets |
567 | | 567 | | ||||||||||||
Other deferred compensation assets |
||||||||||||||||
Large capitalization registered investment companies |
62 | 62 | | | ||||||||||||
Mid capitalization registered investment companies |
4 | 4 | | | ||||||||||||
Small capitalization registered investment companies |
7 | 7 | | | ||||||||||||
International developed and emerging markets registered investment companies |
38 | 38 | | | ||||||||||||
Fixed income registered investment companies |
10 | 10 | | | ||||||||||||
Total |
$ | 2,638 | $ | 121 | $ | 2,517 | $ | | ||||||||
Fair Value as of September 30, 2010 |
Fair Value Measurements at September 30, 2010 Using Fair Value Hierarchy |
|||||||||||||||
Level 1 | Level 2 | Level 3 | ||||||||||||||
Liabilities |
||||||||||||||||
Deferred compensation liabilities |
||||||||||||||||
Large capitalization registered investment companies |
$ | 544 | $ | 544 | $ | | $ | | ||||||||
Mid capitalization registered investment companies |
79 | 79 | | | ||||||||||||
Small capitalization registered investment companies |
161 | 161 | | | ||||||||||||
International developed and emerging markets registered investment companies |
200 | 200 | | | ||||||||||||
Fixed income registered investment companies |
53 | 53 | | | ||||||||||||
Fixed general account |
179 | | 179 | | ||||||||||||
Interest rate derivatives |
1,366 | | 1,366 | | ||||||||||||
Total |
$ | 2,582 | $ | 1,037 | $ | 1,545 | $ | | ||||||||
Fair Value as of December 31, 2009 |
Fair Value Measurements at December 31, 2009 Using Fair Value Hierarchy |
|||||||||||||||
Level 1 | Level 2 | Level 3 | ||||||||||||||
Assets |
||||||||||||||||
Company-owned life insurance |
$ | 1,869 | $ | | $ | 1,869 | $ | | ||||||||
Company-owned life insurance - Deferred compensation assets |
622 | | 622 | | ||||||||||||
Other deferred compensation assets |
||||||||||||||||
Large capitalization registered investment companies |
64 | 64 | | | ||||||||||||
Mid capitalization registered investment companies |
4 | 4 | | | ||||||||||||
Small capitalization registered investment companies |
7 | 7 | | | ||||||||||||
International developed and emerging markets registered investment companies |
39 | 39 | | | ||||||||||||
Fixed income registered investment companies |
11 | 11 | | | ||||||||||||
Total |
$ | 2,616 | $ | 125 | $ | 2,491 | $ | | ||||||||
8
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
Fair Value as of December 31, 2009 |
Fair Value Measurements at December 31, 2009 Using Fair Value Hierarchy |
|||||||||||||||
Level 1 | Level 2 | Level 3 | ||||||||||||||
Liabilities |
||||||||||||||||
Deferred compensation liabilities |
||||||||||||||||
Large capitalization registered investment companies |
$ | 557 | $ | 557 | $ | | $ | | ||||||||
Mid capitalization registered investment companies |
98 | 98 | | | ||||||||||||
Small capitalization registered investment companies |
108 | 108 | | | ||||||||||||
International developed and emerging markets registered investment companies |
205 | 205 | | | ||||||||||||
Fixed income registered investment companies |
64 | 64 | | | ||||||||||||
Fixed general account |
184 | | 184 | | ||||||||||||
Interest rate derivatives |
2,160 | | 2,160 | | ||||||||||||
Total |
$ | 3,376 | $ | 1,032 | $ | 2,344 | $ | | ||||||||
The fair values of Company-owned life insurance (COLI) and COLI deferred compensation assets are based on quotes for like instruments with similar credit ratings and terms. The fair values of Other deferred compensation assets and liabilities are based on quoted prices in active markets, with the exception of fixed general account, which is based on quotes for like instruments with similar credit ratings and terms. The fair values of interest rate derivatives are based on quoted market prices from various banks for similar instruments. Upon review of the underlying assets upon which the deferred compensation liabilities are based, the Company reclassified the fixed general account from Level 1 to Level 2 as of December 31, 2009.
Note 6 Hedging Activities
The Company is exposed to the impact of changes in interest rates, foreign currency fluctuations, changes in commodity prices and credit risk. The Company does not use derivative instruments to mitigate the risks associated with foreign currency fluctuations, changes in commodity prices or credit risk. Quaker uses interest rate swaps to mitigate the impact of changes in interest rates. The swaps convert a portion of the Companys variable interest rate debt to fixed interest rate debt and are designated as cash flow hedges and reported on the balance sheet at fair value. The effective portions of the hedges are reported in Other Comprehensive Income (OCI) until reclassified to earnings during the same period the hedged item affects earnings. The Company has no derivatives designated as fair value hedges and only has derivatives designated as hedging instruments under the FASBs guidance. The notional amount of the Companys interest rate swaps was $30,000 and $40,000 as of September 30, 2010 and December 31, 2009, respectively.
Information about the Companys interest rate derivatives is as follows:
Balance Sheet Location | Fair Value | |||||||||||
September 30, 2010 |
December 31, 2009 |
|||||||||||
Derivatives designated as cash flow hedges: |
||||||||||||
Interest rate swaps |
Other current liabilities | $ | 173 | $ | 1,006 | |||||||
Interest rate swaps |
Other non-current liabilities | 1,193 | 1,154 | |||||||||
$ | 1,366 | $ | 2,160 | |||||||||
9
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
Cash Flow Hedges
Interest Rate Swaps
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||||||
Amount of Gain (Loss) Recognized in Accumulated OCI on Derivative (Effective Portion) |
$ | 191 | $ | 21 | $ | 487 | $ | 389 | ||||||||||||
Amount and Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |
Interest Expense | $ | (444 | ) | $ | (430 | ) | $ | (1,352 | ) | $ | (1,135 | ) | |||||||
Amount and Location of Gain (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing) |
Other Income | $ | | $ | | $ | | $ | | |||||||||||
Note 7 Stock-Based Compensation
The Company recognized approximately $2,371 of share-based compensation expense for the nine months ended September 30, 2010. The compensation expense was comprised of $301 related to stock options, $834 related to nonvested stock awards, $31 related to the Companys Employee Stock Purchase Plan, $1,108 related to the Companys non-elective 401(k) matching contribution in stock and $97 related to the Companys Director Stock Ownership Plan.
Based on historical experience, the Company has assumed a forfeiture rate of 13% on the nonvested stock. The Company will record additional expense if the actual forfeiture rate is lower than estimated, and will record a recovery of prior expense if the actual forfeiture is higher than estimated.
The Company has a long-term incentive program (LTIP) for key employees which provides for the granting of options to purchase stock at prices not less than market value on the date of the grant. Most options become exercisable between one and three years after the date of the grant for a period of time determined by the Company not to exceed seven years from the date of grant. Common stock awards issued under the LTIP program are subject only to time vesting over a three to five-year period. In addition, as part of the Companys Global Annual Incentive Plan (GAIP), nonvested shares may be issued to key employees, which generally vest over a two to five-year period.
Stock option activity under all plans is as follows:
Number of Shares |
Weighted Average Exercise Price per Share |
Weighted
Average Remaining Contractual Term (years) |
||||||||||
Balance at December 31, 2009 |
526,508 | $ | 16.66 | |||||||||
Options granted |
110,939 | 18.82 | ||||||||||
Options exercised |
(187,666 | ) | 19.15 | |||||||||
Options expired |
(9,100 | ) | 20.71 | |||||||||
Balance at September 30, 2010 |
440,681 | $ | 16.06 | 4.2 | ||||||||
Exercisable at September 30, 2010 |
201,700 | $ | 19.25 | 2.4 | ||||||||
As of September 30, 2010, the total intrinsic value of options outstanding was approximately $7,346, and the total intrinsic value of exercisable options was approximately $2,718. Intrinsic value is calculated as the difference between the current market price of the underlying security and the strike price of a related option.
10
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
A summary of the Companys outstanding stock options at September 30, 2010 is as follows:
Range of Exercise Prices |
Number Outstanding at 9/30/2010 |
Weighted Average Contractual Life |
Weighted Average Exercise Price |
Number Exercisable at 9/30/2010 |
Weighted Average Exercise Price |
|||||||||||||||
$5.33 - $7.98 |
143,813 | 5.4 | $ | 6.93 | 33,156 | $ | 6.93 | |||||||||||||
$7.99 - $18.62 |
| | | | | |||||||||||||||
$18.63 - $21.28 |
197,292 | 4.7 | 19.13 | 68,968 | 19.55 | |||||||||||||||
$21.29 - $23.94 |
96,976 | 1.6 | 23.07 | 96,976 | 23.07 | |||||||||||||||
$23.95 - $26.60 |
2,600 | 0.1 | 26.05 | 2,600 | 26.05 | |||||||||||||||
440,681 | 4.2 | 16.06 | 201,700 | 19.25 | ||||||||||||||||
As of September 30, 2010, unrecognized compensation expense related to options granted during 2008 was $24, for options granted during 2009 was $159 and for options granted during 2010 was $533.
During the first quarter of 2010, the Company granted 110,939 stock options under the Companys LTIP plan that are subject only to time vesting over a three-year period. The options were valued using the Black-Scholes model with the following assumptions: dividend yield of 5.1%, expected volatility of 53.72%, a risk-free interest rate of 2.85%, an expected term of six years, and a forfeiture rate of 3% over the remaining life of the options. Approximately $152 of expense was recorded on these options during the first nine months of 2010. The fair value of these awards is amortized on a straight-line basis over the vesting period of the awards.
Under the Companys LTIP plan, 158,207 shares of nonvested stock were outstanding at December 31, 2009. In the first quarter of 2010, 41,204 shares of nonvested stock were granted at a weighted average grant date fair value of $18.82. In the second quarter of 2010, 11,096 shares of nonvested stock were granted to Directors at a weighted average grant date fair value of $25.94. As of September 30, 2010, 5,100 shares were forfeited, 40,531 shares vested and 164,876 were outstanding. The fair value of the nonvested stock is based on the trading price of the Companys common stock on the date of grant. The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards. As of September 30, 2010, unrecognized compensation expense related to these awards was $1,145, to be recognized over a weighted average remaining period of 1.73 years.
Under the Companys GAIP plan, 69,675 shares were outstanding at December 31, 2009. Through September 30, 2010, no shares were granted, 4,375 shares vested, 1,550 shares were forfeited and 63,750 shares were outstanding. As of September 30, 2010, unrecognized compensation expense related to these awards was $246, to be recognized over a weighted average remaining period of 1.50 years.
Employee Stock Purchase Plan
In 2000, the Board adopted an Employee Stock Purchase Plan (ESPP) whereby employees may purchase Company stock through a payroll deduction plan. Purchases are made from the plan and credited to each participants account at the end of each month, the Investment Date. The purchase price of the stock is 85% of the fair market value on the Investment Date. The plan is compensatory and the 15% discount is expensed on the Investment Date. All employees, including officers, are eligible to participate in this plan. A participant may withdraw all uninvested payment balances credited to a participants account at any time by giving written notice to the Committee designated by the Board. An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.
11
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
2003 Director Stock Ownership Plan
In March 2003, the Companys Board of Directors approved a stock ownership plan for each member of the Companys Board to encourage the Directors to increase their investment in the Company. The Plan was effective on the date it was approved and remains in effect for a term of ten years or until it is earlier terminated by the Board. The maximum number of shares of Common Stock which may be issued under the Plan is 75,000, subject to certain conditions that the Compensation/Management Development Committee (the Committee) may elect to adjust the number of shares. As of September 30, 2010, the Committee has not made any elections to adjust the shares under this plan. Each Director is eligible to receive an annual retainer for services rendered as a member of the Board of Directors. Currently, each Director who owns less than 7,500 shares of Company Common Stock is required to receive 75% of the annual retainer in Common Stock and 25% of the annual retainer in cash. Each Director who owns 7,500 or more shares of Company Common Stock receives 25% of the annual retainer in Common Stock and 75% of the annual retainer in cash with the option to receive Common Stock in lieu of the cash portion of the retainer. Currently, the annual retainer is $40. The number of shares issued in payment of the fees is calculated based on an amount equal to the average of the closing prices per share of Common Stock as reported on the composite tape of the New York Stock Exchange for the two trading days immediately preceding the retainer payment date. The retainer payment date is June 1. For the three and nine months ended September 30, 2010, the Company recorded approximately $32 and $97 of compensation expense, respectively. For the three and nine months ended September 30, 2009, the Company recorded approximately $32 and $96, respectively.
Note 8 Earnings Per Share
The Company applies FASBs guidance regarding the calculation of earnings per share using the two-class method. The Company includes nonvested stock awards with rights to non-forfeitable dividends as part of its basic weighted average share calculation.
The following table summarizes earnings per share (EPS) calculations:
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Basic Earnings per Common Share |
||||||||||||||||
Net income attributable to Quaker Chemical Corporation |
$ | 6,340 | $ | 5,052 | $ | 24,912 | $ | 8,288 | ||||||||
Less: income allocated to participating securities |
(126 | ) | (102 | ) | (522 | ) | (131 | ) | ||||||||
Net income available to common shareholders |
$ | 6,214 | $ | 4,950 | $ | 24,390 | $ | 8,157 | ||||||||
Basic weighted average common shares outstanding |
11,088,830 | 10,834,048 | 10,981,302 | 10,791,629 | ||||||||||||
Basic earnings per common share |
$ | 0.56 | $ | 0.46 | $ | 2.22 | $ | 0.76 | ||||||||
Diluted Earnings per Common Share |
||||||||||||||||
Net income attributable to Quaker Chemical Corporation |
$ | 6,340 | $ | 5,052 | $ | 24,912 | $ | 8,288 | ||||||||
Less: income allocated to participating securities |
(125 | ) | (101 | ) | (516 | ) | (131 | ) | ||||||||
Net income available to common shareholders |
$ | 6,215 | $ | 4,951 | $ | 24,396 | $ | 8,157 | ||||||||
Basic weighted average common shares outstanding |
11,088,830 | 10,834,048 | 10,981,302 | 10,791,629 | ||||||||||||
Effect of dilutive securities, common shares outstanding |
209,624 | 89,579 | 181,620 | 43,118 | ||||||||||||
Diluted weighted average common shares outstanding |
11,298,454 | 10,923,627 | 11,162,922 | 10,834,747 | ||||||||||||
Diluted earnings per common share |
$ | 0.55 | $ | 0.45 | $ | 2.19 | $ | 0.75 |
The following numbers of stock options are not included in the earnings per share since in each case the exercise price is greater than the market price: 0 and 360,518 for the three months ended September 30, 2010 and 2009, and 0 and 360,518 for the nine months ended September 30, 2010 and 2009, respectively.
Note 9 Business Segments
The Company organizes its segments by type of product sold. The Companys reportable segments are as follows:
(1) Metalworking process chemicals industrial process fluids for various heavy industrial and manufacturing applications.
(2) Coatings temporary and permanent coatings for metal and concrete products and chemical milling maskants.
(3) Other chemical products other various chemical products.
12
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
Segment data includes direct segment costs as well as general operating costs.
The table below presents information about the reported segments:
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Metalworking Process Chemicals |
||||||||||||||||
Net sales |
$ | 128,764 | $ | 109,989 | $ | 376,931 | $ | 294,348 | ||||||||
Operating income |
25,290 | 22,448 | 75,926 | 47,859 | ||||||||||||
Coatings |
||||||||||||||||
Net sales |
8,424 | 8,494 | 23,698 | 24,049 | ||||||||||||
Operating income |
1,980 | 2,133 | 5,306 | 5,757 | ||||||||||||
Other Chemical Products |
||||||||||||||||
Net sales |
481 | 439 | 1,351 | 1,367 | ||||||||||||
Operating loss |
(6 | ) | (16 | ) | (40 | ) | (106 | ) | ||||||||
Total |
||||||||||||||||
Net sales |
137,669 | 118,922 | 401,980 | 319,764 | ||||||||||||
Operating income |
27,264 | 24,565 | 81,192 | 53,510 | ||||||||||||
Non-operating expenses |
(12,661 | ) | (14,464 | ) | (39,043 | ) | (33,883 | ) | ||||||||
Contingencies charge (Refer to Note 15 Commitments and Contingencies) |
(3,581 | ) | | (3,581 | ) | | ||||||||||
CEO transition costs |
(1,317 | ) | (1,250 | ) | (1,317 | ) | (2,443 | ) | ||||||||
Restructuring and related charges |
| | | (2,289 | ) | |||||||||||
Amortization |
(274 | ) | (275 | ) | (736 | ) | (797 | ) | ||||||||
Interest expense |
(1,345 | ) | (1,356 | ) | (4,042 | ) | (4,136 | ) | ||||||||
Interest income |
313 | 178 | 840 | 551 | ||||||||||||
Other (expense) income, net |
(320 | ) | 217 | 1,566 | 2,027 | |||||||||||
Consolidated income before taxes and equity in net income of associated companies |
$ | 8,079 | $ | 7,615 | $ | 34,879 | $ | 12,540 | ||||||||
Operating income comprises revenue less related costs and expenses. Non-operating items primarily consist of general corporate expenses identified as not being a cost of operation, interest expense, interest income, and license fees from non-consolidated associates.
13
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
Note 10 Equity, Noncontrolling Interest and Comprehensive Income
The following table presents the changes in equity, noncontrolling interest and comprehensive income for the three and nine months ended September 30, 2010 and 2009:
Common stock |
Capital in excess of par value |
Retained earnings |
Accumulated other comprehensive loss |
Noncontrolling Interest |
Comprehensive Income |
Total | ||||||||||||||||||||||
Balance at June 30, 2010 |
$ | 11,259 | $ | 32,798 | $ | 136,497 | $ | (20,070 | ) | $ | 6,063 | $ | 166,547 | |||||||||||||||
Net income |
| | 6,340 | 517 | $ | 6,857 | ||||||||||||||||||||||
Currency translation adjustments |
| | | 11,085 | 493 | 11,578 | ||||||||||||||||||||||
Defined benefit retirement plans |
| | | 862 | | 862 | ||||||||||||||||||||||
Current period changes in fair value of derivatives |
| | | 191 | | 191 | ||||||||||||||||||||||
Unrealized loss on available-for-sale securities |
| | | 13 | | 13 | ||||||||||||||||||||||
Comprehensive income |
19,501 | 19,501 | ||||||||||||||||||||||||||
Comprehensive loss attributable to noncontrolling interest |
(1,010 | ) | ||||||||||||||||||||||||||
Comprehensive income attributable to Quaker Chemical Corporation |
$ | 18,491 | ||||||||||||||||||||||||||
Dividends ($0.235 per share) |
| | (2,676 | ) | | | (2,676 | ) | ||||||||||||||||||||
Share issuance and equity-based compensation plans |
117 | 2,757 | | | | 2,874 | ||||||||||||||||||||||
Excess tax benefit from stock option exercises |
| 176 | | | | 176 | ||||||||||||||||||||||
Balance at September 30, 2010 |
$ | 11,376 | $ | 35,731 | $ | 140,161 | $ | (7,919 | ) | $ | 7,073 | $ | 186,422 | |||||||||||||||
Balance at June 30, 2009 |
$ | 11,050 | $ | 26,210 | $ | 115,254 | $ | (19,987 | ) | $ | 4,693 | $ | 137,220 | |||||||||||||||
Net income |
| | 5,052 | 371 | $ | 5,423 | ||||||||||||||||||||||
Currency translation adjustments |
| | | 4,758 | 168 | 4,926 | ||||||||||||||||||||||
Defined benefit retirement plans |
| | | 676 | | 676 | ||||||||||||||||||||||
Current period changes in fair value of derivatives |
| | | 21 | | 21 | ||||||||||||||||||||||
Unrealized gain on available-for-sale securities |
| | | 17 | | 17 | ||||||||||||||||||||||
Comprehensive income |
11,063 | 11,063 | ||||||||||||||||||||||||||
Comprehensive loss attributable to noncontrolling interest |
(539 | ) | ||||||||||||||||||||||||||
Comprehensive income attributable to Quaker Chemical Corporation |
$ | 10,524 | ||||||||||||||||||||||||||
Dividends ($0.23 per share) |
| | (2,549 | ) | | (2,549 | ) | |||||||||||||||||||||
Dividends paid to noncontrolling shareholders |
| | | | (184 | ) | (184 | ) | ||||||||||||||||||||
Share issuance and equity-based compensation plans |
22 | 727 | | | | 749 | ||||||||||||||||||||||
Balance at September 30, 2009 |
$ | 11,072 | $ | 26,937 | $ | 117,757 | $ | (14,515 | ) | $ | 5,048 | $ | 146,299 | |||||||||||||||
Common stock |
Capital in excess of par value |
Retained earnings |
Accumulated other comprehensive loss |
Noncontrolling Interest |
Comprehensive Income |
Total | ||||||||||||||||||||||
Balance at December 31, 2009 |
$ | 11,086 | $ | 27,527 | $ | 123,140 | $ | (10,439 | ) | $ | 4,981 | $ | 156,295 | |||||||||||||||
Net income |
| | 24,912 | 1,716 | $ | 26,628 | ||||||||||||||||||||||
Currency translation adjustments |
| | | 629 | 376 | 1,005 | ||||||||||||||||||||||
Defined benefit retirement plans |
| | | 1,400 | | 1,400 | ||||||||||||||||||||||
Current period changes in fair value of derivatives |
| | | 487 | | 487 | ||||||||||||||||||||||
Unrealized loss on available-for-sale securities |
| | | 4 | | 4 | ||||||||||||||||||||||
Comprehensive income |
29,524 | 29,524 | ||||||||||||||||||||||||||
Comprehensive loss attributable to noncontrolling interest |
(2,092 | ) | ||||||||||||||||||||||||||
Comprehensive income attributable to Quaker Chemical Corporation |
$ | 27,432 | ||||||||||||||||||||||||||
Dividends ($0.70 per share) |
| | (7,891 | ) | | | (7,891 | ) | ||||||||||||||||||||
Share issuance and equity-based compensation plans |
290 | 5,910 | | | | 6,200 | ||||||||||||||||||||||
Excess tax benefit from stock option exercises |
| 2,294 | | | | 2,294 | ||||||||||||||||||||||
Balance at September 30, 2010 |
$ | 11,376 | $ | 35,731 | $ | 140,161 | $ | (7,919 | ) | $ | 7,073 | $ | 186,422 | |||||||||||||||
Balance at December 31, 2008 |
$ | 10,833 | $ | 25,238 | $ | 117,089 | $ | (27,237 | ) | $ | 3,952 | $ | 129,875 | |||||||||||||||
Net income |
| | 8,288 | 829 | $ | 9,117 | ||||||||||||||||||||||
Currency translation adjustments |
| | | 10,365 | 541 | 10,906 | ||||||||||||||||||||||
Defined benefit retirement plans |
| | | 1,945 | | 1,945 | ||||||||||||||||||||||
Current period changes in fair value of derivatives |
| | | 389 | | 389 | ||||||||||||||||||||||
Unrealized gain on available-for-sale securities |
| | | 23 | | 23 | ||||||||||||||||||||||
Comprehensive income |
22,380 | 22,380 | ||||||||||||||||||||||||||
Comprehensive loss attributable to noncontrolling interest |
(1,370 | ) | ||||||||||||||||||||||||||
Comprehensive income attributable to Quaker Chemical Corporation |
$ | 21,010 | ||||||||||||||||||||||||||
Dividends ($0.69 per share) |
| | (7,620 | ) | | | (7,620 | ) | ||||||||||||||||||||
Dividends paid to noncontrolling shareholders |
| | | | (274 | ) | (274 | ) | ||||||||||||||||||||
Share issuance and equity-based compensation plans |
239 | 1,699 | | | | 1,938 | ||||||||||||||||||||||
Balance at September 30, 2009 |
$ | 11,072 | $ | 26,937 | $ | 117,757 | $ | (14,515 | ) | $ | 5,048 | $ | 146,299 | |||||||||||||||
14
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
During the first nine months of 2010, the Company recorded $2,294 of excess tax benefits in capital in excess of par value on its Condensed Consolidated Balance Sheet related to stock option exercises, which occurred over the current and prior years. Previously, the Companys actual taxable income in affected jurisdictions was not sufficient to recognize these benefits, while the Companys full-year 2010 projection of taxable income is expected to be sufficient to recognize these benefits. As a result, the Company recognized these benefits as a cash inflow from financing activities in its Condensed Consolidated Statement of Cash Flows which represents the Companys estimate of cash savings through September 30, 2010.
Note 11 Debt
In June 2010, the Company amended its primary credit facility to increase the maximum principal amount available for revolving credit borrowings from $125,000 to $175,000. This amount can be increased to $225,000 at the Companys option if the lenders agree to increase their commitments and the Company satisfies certain conditions. The amendment also extended the maturity date of the Companys credit line from August 2012 to June 2014 and amended certain acquisition and other covenants, including a reduced interest rate spread and a new interest rate tier for leverage ratios below one times EBITDA that would allow for a further interest rate spread reduction. Under the amendment, the Company is still subject to the financial covenants under the facility, all of which the Company was in compliance with at September 30, 2010.
Note 12 Acquisitions
In July 2010, the Company completed the acquisition of the assets of D.A. Stuarts U.S. aluminum hot rolling oil business from Houghton International for $6,862, subject to a post closing working capital adjustment. This acquisition strategically strengthens the Companys position in the non-ferrous industry, as the acquired product portfolio is complementary to its existing business. The Company allocated $2,351 to intangible assets, comprised of customer lists, to be amortized over 15 years, trade names, to be amortized over 10 years and a trademark, to be amortized over one year. In addition, the Company recorded $3,125 of goodwill, all of which will be tax-deductible, and was assigned to the metalworking process chemicals segment. The following table shows the allocation of the purchase price of the assets acquired. The pro forma results of operations have not been provided because the effects were not material:
September 30, 2010 |
||||
Current assets |
$ | 1,253 | ||
Fixed assets |
133 | |||
Intangibles |
2,351 | |||
Goodwill |
3,125 | |||
Total assets |
6,862 | |||
Liabilities assumed |
| |||
Cash Paid |
$ | 6,862 | ||
Note 13 Goodwill and Other Intangible Assets
The Company completed its annual impairment assessment as of the end of the third quarter of 2010 and no impairment charge was warranted. The Company has recorded no impairment charges in the past. The changes in carrying amount of goodwill for the nine months ended September 30, 2010 are as follows:
Metalworking Process Chemicals |
Coatings | Total | ||||||||||
Balance as of December 31, 2009 |
$ | 38,434 | $ | 8,081 | $ | 46,515 | ||||||
Goodwill additions |
3,125 | | 3,125 | |||||||||
Currency translation adjustments |
(147 | ) | | (147 | ) | |||||||
Balance as of September 30, 2010 |
$ | 41,412 | $ | 8,081 | $ | 49,493 | ||||||
15
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of September 30, 2010 and December 31, 2009 are as follows:
Gross Carrying Amount |
Accumulated Amortization |
|||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Amortized intangible assets |
||||||||||||||||
Customer lists and rights to sell |
$ | 10,388 | $ | 8,373 | $ | 4,820 | $ | 4,428 | ||||||||
Trademarks and patents |
2,035 | 1,788 | 1,793 | 1,788 | ||||||||||||
Formulations and product technology |
3,278 | 3,278 | 2,643 | 2,450 | ||||||||||||
Other |
3,405 | 3,409 | 3,275 | 3,203 | ||||||||||||
Total |
$ | 19,106 | $ | 16,848 | $ | 12,531 | $ | 11,869 | ||||||||
The Company recorded $736 and $797 of amortization expense in the first nine months of 2010 and 2009, respectively. Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:
For the year ended December 31, 2010 |
$ | 986 | ||
For the year ended December 31, 2011 |
$ | 975 | ||
For the year ended December 31, 2012 |
$ | 876 | ||
For the year ended December 31, 2013 |
$ | 699 | ||
For the year ended December 31, 2014 |
$ | 468 | ||
For the year ended December 31, 2015 |
$ | 468 |
The Company has one indefinite-lived intangible asset of $600 for trademarks recorded in connection with the Companys 2002 acquisition of Epmar.
Note 14 Pension and Other Postretirement Benefits
The components of net periodic benefit cost, for the three and nine months ended September 30, are as follows:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||
Pension Benefits | Other Postretirement Benefits |
Pension Benefits | Other Postretirement Benefits |
|||||||||||||||||||||||||||||
2010 | 2009 | 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | |||||||||||||||||||||||||
Service cost |
$ | 487 | $ | 540 | $ | 5 | $ | 5 | $ | 1,478 | $ | 1,555 | $ | 14 | $ | 15 | ||||||||||||||||
Interest cost and other |
1,495 | 1,647 | 99 | 143 | 4,507 | 4,859 | 296 | 428 | ||||||||||||||||||||||||
Expected return on plan assets |
(1,354 | ) | (1,234 | ) | | | (4,082 | ) | (3,623 | ) | | | ||||||||||||||||||||
Settlement charge |
1,317 | 1,250 | | | 1,317 | 2,443 | | | ||||||||||||||||||||||||
Other amortization, net |
402 | 406 | 12 | 25 | 1,206 | 1,237 | 38 | 75 | ||||||||||||||||||||||||
Net periodic benefit cost |
$ | 2,347 | $ | 2,609 | $ | 116 | $ | 173 | $ | 4,426 | $ | 6,471 | $ | 348 | $ | 518 | ||||||||||||||||
Employer Contributions:
The Company previously disclosed in its financial statements for the year ended December 31, 2009, that it expected to make minimum cash contributions of $8,578 to its pension plans and $802 to its other postretirement benefit plan in 2010. As of September 30, 2010, $7,530 and $596 of contributions have been made, respectively.
During the nine months ended September 30, 2010, the Company recorded a final settlement charge of $1,317 in connection with the retirement of the Companys former CEO in the third quarter of 2008. The Company recorded $2,443 of settlement charges during the nine months ended September 30, 2009.
Note 15 Commitments and Contingencies
In April of 1992, the Company identified certain soil and groundwater contamination at AC Products, Inc. (ACP), a wholly owned subsidiary. In voluntary coordination with the Santa Ana California Regional Water Quality Board, ACP has been remediating the contamination, the principal contaminant of which is perchloroethylene (PERC). On or about December 18, 2004, the Orange County Water District (OCWD) filed a civil complaint in Superior Court, in Orange County, California against ACP and other parties potentially responsible for groundwater contamination. OCWD was seeking to recover compensatory and other damages related to the investigation and remediation of the contamination in the groundwater. Effective October 17, 2007, ACP and OCWD settled all claims related to this litigation. Pursuant to the settlement agreement with OCWD, ACP agreed to pay $2,000 in two equal payments of $1,000 (the first payment paid October 31, 2007 and the second payment paid on February 15, 2008). In addition to the $2,000 payment, ACP agreed to operate the two existing groundwater treatment systems associated with its extraction wells P-2 and
16
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
P-3 so as to hydraulically contain groundwater contamination emanating from ACPs site until such time as the concentrations of PERC are below the Federal maximum contaminant level for four consecutive quarterly sampling events. During the third quarter of 2007, the Company recognized a $3,300 charge made up of $2,000 for the settlement of the litigation, plus an increase in its reserve for its soil and water remediation program of $1,300. As of September 30, 2010, the Company believes that the range of potential-known liabilities associated with ACP contamination, including the water and soil remediation program, is approximately $1,500 to $2,600, for which the Company has sufficient reserves.
The low and high ends of the range are based on the length of operation of the two extraction wells as determined by groundwater modeling with planned higher maintenance costs in later years if a longer treatment period is required. Costs of operation include the operation and maintenance of the extraction wells, groundwater monitoring and program management. The duration of the well operation was estimated based on historical trends in concentrations in the monitoring wells within the proximity of the applicable extraction wells. Also factored into the model was the impact of water injected into the underground aquifer from a recharge basin adjacent to the ACP site as well as from an injection well to be installed and operated by OCWD as part of the groundwater treatment system for contaminants which are the subject of the aforementioned litigation. Based on the modeling, it is estimated that P-2 will operate for approximately two years and P-3 will operate for three years to up to six years. Operation and maintenance costs were based on historical expenditures and estimated inflation. As mentioned above, a significantly higher maintenance expense was factored into the range if the system operates for the longer period. Also included in the reserve are anticipated expenditures to operate an on-site soil vapor extraction system.
The Company believes, although there can be no assurance regarding the outcome of other unrelated environmental matters, that it has made adequate accruals for costs associated with other environmental problems of which it is aware. Approximately $99 was accrued at September 30, 2010 and December 31, 2009, respectively, to provide for such anticipated future environmental assessments and remediation costs.
An inactive subsidiary of the Company that was acquired in 1978 sold certain products containing asbestos, primarily on an installed basis, and is among the defendants in numerous lawsuits alleging injury due to exposure to asbestos. The subsidiary discontinued operations in 1991 and has no remaining assets other than the proceeds from insurance settlements received. To date, the overwhelming majority of these claims have been disposed of without payment and there have been no adverse judgments against the subsidiary. Based on a continued analysis of the existing and anticipated future claims against this subsidiary, it is currently projected that the subsidiarys total liability over the next 50 years for these claims is approximately $8,500 (excluding costs of defense). Although the Company has also been named as a defendant in certain of these cases, no claims have been actively pursued against the Company, and the Company has not contributed to the defense or settlement of any of these cases pursued against the subsidiary. These cases were handled by the subsidiarys primary and excess insurers who had agreed in 1997 to pay all defense costs and be responsible for all damages assessed against the subsidiary arising out of existing and future asbestos claims up to the aggregate limits of the policies. A significant portion of this primary insurance coverage was provided by an insurer that is now insolvent, and the other primary insurers have asserted that the aggregate limits of their policies have been exhausted. The subsidiary challenged the applicability of these limits to the claims being brought against the subsidiary. In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in late 2005 and in the first quarter of 2007 for $15,000 and $20,000, respectively. The payments under the latest settlement and release agreement were structured to be received over a four-year period with annual installments of $5,000, the final installment of which was received in the first quarter of 2010. The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiarys asbestos litigation. During the third quarter of 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier will pay 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims for a minimum of five years beginning July 1, 2007. At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits. The Company also believes, that if the coverage issues under the primary policies with the remaining carrier are resolved adversely to the subsidiary and all settlement proceeds were used, the subsidiary may have limited additional coverage from a state guarantee fund established following the insolvency of one of the subsidiarys primary insurers. Nevertheless, liabilities in respect of claims may exceed the assets and coverage available to the subsidiary.
If the subsidiarys assets and insurance coverage were to be exhausted, claimants of the subsidiary may actively pursue claims against the Company because of the parent-subsidiary relationship. Although asbestos litigation is particularly difficult to predict, especially with respect to claims that are currently not being actively pursued against the Company, the Company does not believe that such claims would have merit or that the Company would be held to have liability for any unsatisfied obligations of the subsidiary as a result of such claims. After evaluating the nature of the claims filed against the subsidiary and the small number of such claims that have resulted in any payment, the potential availability of additional insurance coverage at the subsidiary level, the additional availability of the Companys own insurance and the Companys strong defenses to claims that it should be held responsible for the
17
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements Continued
(Dollars in thousands, except per share amounts)
(Unaudited)
subsidiarys obligations because of the parent-subsidiary relationship, the Company believes it is not probable that the Company will incur any material losses. All of the asbestos cases pursued against the Company challenging the parent-subsidiary relationship are in the early stages of litigation. The Company has been successful in the past having claims naming it dismissed during initial proceedings. Since the Company may be in this early stage of litigation for some time, it is not possible to estimate additional losses or range of loss, if any.
As previously disclosed in the Companys second quarter Form 10-Q, one of the Companys subsidiaries discovered that it may have paid certain value-added-taxes (VAT) incorrectly and, in certain cases, may not have collected sufficient VAT from certain customers. The VAT rules and regulations at issue are complex, vary among the jurisdictions and can be contradictory, in particular as to how they relate to the subsidiarys products and to sales between jurisdictions.
Since its inception, the subsidiary had been consistent in its VAT collection and remittance practices and had never been contacted by any tax authority relative to VAT. Now the subsidiary has determined that for certain products, a portion of the VAT was incorrectly paid and that the total VAT due exceeds the amount originally collected and remitted by the subsidiary. In 2010, several jurisdictions have contacted the subsidiary requesting information, but no tax assessments have been received. At this time, the subsidiary has either modified or is in the process of modifying its VAT invoicing and payment procedures to eliminate or mitigate future exposure.
In analyzing the subsidiarys exposure, it is difficult to estimate both the probability and the amount of any potential liabilities due to a number of factors, including: the decrease in exposure over time due to applicable statutes of limitations and actions taken by the subsidiary, the joint liability of customers and suppliers for a portion of the VAT, the availability of a VAT refund for VAT incorrectly paid through an administrative process, any amounts which may have already been or will be paid by customers, as well as the timing and structure of any tax amnesties or settlements. In addition, interest and penalties on any VAT due can be a multiple of the base tax. The subsidiary may contest any tax assessment administratively and/or judicially for an extended period of time and tax amnesties have historically occurred on a regular basis, resulting in significant reductions of interest and penalties and are a common practice for settling tax disputes in the jurisdictions in question. Also, the timing of payments and refunds of VAT may not be contemporaneous, and, if additional VAT is owed, it may not be fully recoverable from customers. As a result, this matter has the potential to have a material adverse impact on the Companys statement of financial position, liquidity and capital resources and the results of operations.
Included in the third quarter results is a net charge of $3,581, which consists of a net $1,416 charge related to a tax dispute settlement entered into by the subsidiary, as well as a net $2,165 charge representing managements best estimate, based on the information available to it, including the factors noted above, of the amount that may be ultimately paid related to the other jurisdictions that have made inquiries. These charges assume a successful recovery of the VAT incorrectly paid, as well as reductions in interest and penalties from anticipated future amnesty programs or settlements. On a similar basis, if all other potentially impacted jurisdictions were to initiate audits and issue assessments, the range of the remaining exposure could be from $0 to $27,000, with one jurisdiction representing approximately 80 percent of this additional exposure. The range of this exposure could be higher if there are assessments but no future amnesty programs or settlements to reduce the interest and penalties.
The Company is party to other litigation which management currently believes will not have a material adverse effect on the Companys results of operations, cash flows or financial condition.
18
Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations. |
Executive Summary
Quaker Chemical Corporation is a leading global provider of process chemicals, chemical specialties, services and technical expertise to a wide range of industries including steel, automotive, mining, aerospace, tube and pipe, coatings and construction materials. Our products, technical solutions and chemical management services (CMS) enhance our customers processes, improve their product quality and lower their costs.
The third quarter 2010 earnings per diluted share of $0.55 represents a 22% increase compared to earnings per diluted share of $0.45 in the third quarter of 2009. The third quarter 2010 results include a $3.6 million, or approximately $0.21 per diluted share, charge related to a non-income tax contingency discussed below.
Product volumes increased 15% in the third quarter of 2010 compared to the third quarter of 2009, driven by continued high steel industry demand in China, Brazil, India and Russia and continued recovery of industrial demand in North America and Europe. The gross margin percentage declined from the third quarter of 2009, but remained flat compared to the second quarter of 2010. The Company has implemented price increases to help partially offset higher raw material costs where necessary. The Companys selling, general and administrative expenses were flat with the third quarter of 2009, as inflationary costs and higher selling costs on increased sales were offset by lower incentive compensation.
In July 2010, the Company completed the acquisition of D.A. Stuarts U.S. aluminum hot rolling oil business from Houghton International, which had net sales of approximately $6.9 million in 2009. With this acquisition, Quaker becomes a leading player in the U.S. aluminum hot rolling market.
With economic activity beginning to plateau in certain markets, the Company anticipates somewhat lower fourth quarter demand due in part to seasonal and other economic factors. The Company continues to experience pressure on its margins as raw material costs have continued to increase, notwithstanding the pricing actions taken in the third quarter of 2010. The Company expects fourth quarter 2010 results to remain strong but below the levels we experienced in the first half of 2010. Longer term, the Company continues to expect solid growth over the next several years due to its leadership positions in faster growing markets and the gradual economic recovery in more mature markets.
Contingency Charge
As previously disclosed in the Companys second quarter Form 10-Q, one of the Companys subsidiaries discovered that it may have paid certain value-added-taxes (VAT) incorrectly and, in certain cases, may not have collected sufficient VAT from certain customers. The VAT rules and regulations at issue are complex, vary among the jurisdictions and can be contradictory, in particular as to how they relate to the subsidiarys products and to sales between jurisdictions.
Since its inception, the subsidiary had been consistent in its VAT collection and remittance practices and had never been contacted by any tax authority relative to VAT. Now the subsidiary has determined that for certain products, a portion of the VAT was incorrectly paid and that the total VAT due exceeds the amount originally collected and remitted by the subsidiary. In 2010, several jurisdictions have contacted the subsidiary requesting information, but no tax assessments have been received. At this time, the subsidiary has either modified or is in the process of modifying its VAT invoicing and payment procedures to eliminate or mitigate future exposure.
In analyzing the subsidiarys exposure, it is difficult to estimate both the probability and the amount of any potential liabilities due to a number of factors, including: the decrease in exposure over time due to applicable statutes of limitations and actions taken by the subsidiary, the joint liability of customers and suppliers for a portion of the VAT, the availability of a VAT refund for VAT incorrectly paid through an administrative process, any amounts which may have already been or will be paid by customers, as well as the timing and structure of any tax amnesties or settlements. In addition, interest and penalties on any VAT due can be a multiple of the base tax. The subsidiary may contest any tax assessment administratively and/or judicially for an extended period of time and tax amnesties have historically occurred on a regular basis resulting in significant reductions of interest and penalties and are a common practice for settling tax disputes in the jurisdictions in question. Also, the timing of payments and refunds of VAT may not be contemporaneous, and, if additional VAT is owed, it may not be fully recoverable from customers. As a result, this matter has the potential to have a material adverse impact on the Companys statement of financial position, liquidity and capital resources and the results of operations.
Included in the third quarter results is a net charge of $3.6 million, which consists of a net $1.4 million charge related to a tax dispute settlement entered into by the subsidiary, as well as a net $2.2 million charge representing managements best estimate, based on the information available to it, including the factors noted above, of the amount that may be ultimately paid related to the other jurisdictions that have made inquiries. These charges assume a successful recovery of the VAT incorrectly paid, as well as reductions
19
in interest and penalties from anticipated future amnesty programs or settlements. On a similar basis, if all other potentially impacted jurisdictions were to initiate audits and issue assessments, the range of the remaining exposure could be from $0 to $27.0 million, with one jurisdiction representing approximately 80 percent of this additional exposure. The range of this exposure could be higher if there are assessments but no future amnesty programs or settlements to reduce the interest and penalties.
CMS Discussion
The Company currently has more than 50 CMS contracts in North America, as well as additional CMS contracts in other areas of the world. Under its traditional CMS approach, the Company effectively acts as an agent, and the revenues and costs from these sales are reported on a net sales or pass-through basis. Under certain of its CMS contracts, the contracts are structured differently in that the Companys revenue received from the customer is a fee for products and services provided to the customer, which are indirectly related to the actual costs incurred. Under this alternative structure, profit is dependent on how well the Company controls product costs and achieves product conversions from other third-party suppliers to its own products. As a result, under this structure, the Company recognizes in reported revenue the gross revenue received from the CMS site customer, and in cost of goods sold the third-party product purchases, which substantially offset each other until the Company achieves significant product conversions, which may result in a decrease in reported gross margin as a percentage of sales.
In 2009, the Company had a mix of contracts with both the traditional product pass-through structure and fixed price contracts covering all services and products. As a result of the global economic downturn and its impact in the automotive sector, during 2009 and early 2010, the Company has experienced a shift in customer requirements and business circumstances where the majority of CMS contracts have reverted to the traditional product pass-through structure. However, the Companys offerings will continue to include both approaches to CMS.
Liquidity and Capital Resources
Quakers cash and cash equivalents increased to $27.1 million at September 30, 2010 from $25.1 million at December 31, 2009. The $2.0 million increase resulted primarily from $19.5 million of cash provided by operating activities, $9.4 million of cash used in investing activities, $8.4 million of cash used in financing activities and a $0.3 million increase from the effect of exchange rates on cash.
Net cash flows provided by operating activities were $19.5 million in the first nine months of 2010, compared to $34.7 million provided by operating activities in the first nine months of 2009. During the first nine months of 2009, the Company experienced significantly lower business activity as it was still recovering from the global economic downturn, which in turn greatly reduced the Companys investment in working capital. As business volumes began to increase in 2009 and continued to increase in the first half of 2010, the Companys need for working capital investment increased. The Companys improvement in net income was more than offset by increased investment in working capital. The Companys first quarter 2009 disposition of land in Europe, reduced pension contributions compared to 2009, and the 2009 completion of restructuring activities also impacted the operating cash flow comparisons.
Net cash flows used in investing activities were $9.4 million in the first nine months of 2010, compared to $3.6 million of cash used in investing activities in the first nine months of 2009. Payments related to acquisitions were the primary driver in the change in cash flows used in investing activities. During the third quarter of 2010, the Company completed the acquisition of D.A. Stuarts U.S. aluminum hot rolling business from Houghton International for $6.9 million, while the first quarter of 2009 included the final $1.0 million payment related to the 2005 acquisition of the remaining 40% interest in the Companys Brazilian joint venture. In addition, the 2009 proceeds from the disposition of land in Europe were offset by lower capital expenditures in 2010 as the Company completed its Middletown, Ohio expansion project. Reductions in the use of restricted cash related to the expansion also affected the investing cash flow comparisons.
In the first quarter of 2007, an inactive subsidiary of the Company reached a settlement agreement and release with one of its insurance carriers for $20.0 million. The proceeds of the settlement are restricted and can only be used to pay claims and costs of defense associated with this subsidiarys asbestos litigation. The payments were structured to be received over a four-year period with annual installments of $5.0 million, the final installment of which was received in the first quarter of 2010. During the third quarter of 2007, the same inactive subsidiary and another of its insurance carriers entered into a Claim Handling and Funding Agreement under which the carrier will pay 27% of the defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims for a minimum of five years beginning July 1, 2007.
Net cash flows used in financing activities were $8.4 million for the first nine months of 2010, compared to $28.7 million of cash used in financing activities for the first nine months of 2009. The majority of the change was the result of higher debt repayments in the first nine months of 2009 compared to the first nine months of 2010. In the first nine months of 2009, the cash flow generated from reduced working capital investments as a result of significantly curtailed business volumes enabled the higher debt repayments. In addition, in the first nine months of 2010, a significantly higher level of stock options were exercised which impacted the change in cash flows.
20
In June 2010, the Company amended its primary credit facility to increase the maximum principal amount available for revolving credit borrowings from $125.0 million to $175.0 million. This amount can be increased to $225.0 million at the Companys option if the lenders agree to increase their commitments and the Company satisfies certain conditions. At September 30, 2010 and December 31, 2009, the Company had approximately $40.0 million and $46.4 million, respectively, outstanding under its credit facilities. The amendment also extended the maturity date of the Companys credit line from August 2012 to June 2014 and amended certain acquisition and other covenants, including a reduced interest rate spread and a new interest rate tier for leverage ratios below one times EBITDA that would allow for a further interest rate spread reduction. The Companys access to this credit is largely dependent on its consolidated leverage ratio covenant, which cannot exceed 3.5 to 1, and at September 30, 2010 and December 31, 2009, the consolidated leverage ratio was below 2.0 to 1. The Company has entered into interest rate swaps with a combined notional value of $30.0 million as of September 30, 2010 in order to fix the interest rate on a portion of its variable rate debt. Outstanding financial derivative instruments may expose the Company to credit loss in the event of nonperformance by the counterparties to the agreements. To manage credit risk, the Company limits its exposure to any single counterparty. However, the Company does not expect any of the counterparties to fail to meet their obligations.
At September 30, 2010, the Companys gross liability for uncertain tax positions, including accrued interest and penalties, was $13.7 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability. However, should the entire liability be paid, the amount of the payment may be reduced by $7.0 million as a result of offsetting benefits in other tax jurisdictions.
The Company completed its annual impairment assessment and no impairment charge was warranted. The companys assumption of weighted average cost of capital and estimated future net operating profit after tax (NOPAT) are particularly important in determining whether an impairment charge has been incurred. The Company currently uses a weighted average cost of capital of 12% and, at September 30, 2010, this assumption would have had to increase by more than 6.75 percentage points before any of the Companys reporting units would fail step one of the impairment analysis. Further, at September 30, 2010, the Companys estimate of future NOPAT would have had to decrease by more than 36% before any of the Companys reporting units would be considered potentially impaired. As a result, the estimated fair value of each of the Companys reporting units substantially exceeds their carrying value.
With operating cash flow of $9.2 million generated in the third quarter of 2010, the Companys net debt-to-total-capital ratio decreased to 15% as of September 30, 2010 compared to 19% as of June 30, 2010 and 20% as of December 31, 2009. The Company believes it is capable of supporting its operating requirements, including pension plan contributions, payments of dividends to shareholders, possible acquisitions and business opportunities, capital expenditures and possible resolution of contingencies through internally generated funds supplemented with debt or equity as needed.
Operations
Comparison of Third Quarter of 2010 with Third Quarter of 2009
Net sales for the third quarter were $137.7 million, up 16% from $118.9 million for the third quarter of 2009. The increase in net sales was primarily the result of a 15% increase in volume, which was experienced across the globe. Selling prices and mix increased revenues by approximately 5%, as the Company implemented price increases to help partially offset higher raw material costs. These increases were partially offset by lower automotive chemical management services (CMS) revenue reported on a gross basis and lower foreign exchange rates, each of which decreased revenues by approximately 2%.
Gross profit increased $4.6 million, or 10%, compared to the third quarter of 2009 as a result of increased volumes. However, gross margin decreased to 35.6% from 37.4% in the third quarter of 2009, primarily driven by increased raw material costs, and is consistent with the second quarter 2010 gross margin percentage.
Selling, general and administrative expenses (SG&A) were flat compared to the third quarter of 2009. Higher selling costs with increased business activity, as well as inflationary increases, were offset by decreases in incentive compensation.
The Company incurred a final charge related to the former CEOs supplemental retirement plan of approximately $1.3 million, or $0.08 per diluted share, in the third quarter of 2010, compared to a charge of $1.3 million, or $0.07 per diluted share, in the third quarter of 2009.
The decrease in other income is due to higher exchange rate losses compared to the third quarter of 2009.
The Companys effective tax rate was 21% in the third quarter of 2010, compared to 36% in the third quarter of 2009. The third quarter 2010 and 2009 effective tax rates include benefits of approximately $0.04 per diluted share and $0.02 per diluted share, respectively, due to the expiration of applicable statutes of limitations for uncertain tax positions. In addition, the third quarter 2010 effective tax rate also reflects increased utilization of foreign tax credits and net operating losses, which were previously not benefited. Many external and internal factors can impact this rate and the Company will continue to refine this rate, if necessary, as the year progresses. Please refer to the Comparison of the First Nine Months of 2010 with the First Nine Months of 2009, below, for further discussion.
21
Segment Reviews Comparison of Third Quarter 2010 with Third Quarter 2009
Metalworking Process Chemicals
Metalworking Process Chemicals consists of industrial process fluids for various heavy industrial and manufacturing applications and represented approximately 94% of the Companys net sales in the third quarter of 2010. Net sales were up $18.8 million, or 17%, compared to the third quarter of 2009. Foreign currency translation negatively impacted net sales by approximately 2%, driven by the Euro to U.S. Dollar exchange rate. The average Euro to U.S. Dollar exchange rate was 1.29 for the third quarter of 2010 compared to 1.43 for the third quarter of 2009. Net sales were positively impacted by increases of 17% in North America, 20% in Europe, 19% in Asia/Pacific and 24% in South America, all on a constant currency basis. The increase in this segments sales was primarily attributable to increased volumes of 17% impacting all regions, as the prior year results continue to reflect the global economic downturn. Additionally, net sales were positively impacted by a 5% increase in selling price and mix, as the Company implemented price increases to help offset higher raw material costs. These increases were partially offset by a reduction in automotive CMS revenue, which was due, in part, to the renegotiation of certain contracts now reported on a pass-through versus gross basis. Consistent with the volume increases, this segments operating income increased $2.8 million, or 13%, compared to the third quarter of 2009.
Coatings
The Companys Coatings segment, which represented approximately 6% of the Companys net sales in the third quarter of 2010, contains products that provide temporary and permanent coatings for metal and concrete products and chemical milling maskants. Net sales for this segment were down 1% for the third quarter of 2010 compared to the third quarter of 2009. This segments operating income was down $0.2 million, related to a decrease in volume as well as due to product mix and increased selling costs.
Other Chemical Products
Other Chemical Products, which represented less than 1% of the Companys net sales in the third quarter of 2010, consists of sulfur removal products for industrial gas streams sold by the Companys Q2 Technologies joint venture. Net sales and operating income improved slightly compared to the third quarter of 2009. However, operating income remains at a slight loss in both periods due to the downturn in the oil and gas market.
Comparison of the First Nine Months of 2010 with the First Nine Months of 2009
Net sales for the first nine months of 2010 were $402.0 million, up 26% from $319.8 million for the first nine months of 2009. The increase in sales was driven by significant increases in volume across the globe, as the comparisons to the prior year continue to reflect recovery from the global economic downturn. The volume increases were partially offset by lower automotive chemical management services (CMS) revenue reported on a gross basis, which decreased revenues by approximately 5%.
Gross profit increased $35.7 million, or 33%, compared to the first nine months of 2009, largely as a result of increased volumes. The year-to-date gross margin increased to 36.0% from 34.2% during the first nine months of 2009, as raw material costs did not begin to significantly increase until the middle of the second quarter of 2010. In addition, reduced automotive CMS revenues reported on a gross basis contributed to the gross margin percentage increase.
SG&A increased $13.1 million, or 14%, compared to the first nine months of 2009. Higher selling costs with increased business activity, inflationary costs as well as increased incentive compensation were the primary drivers, representing 85% of the increase. Differences in foreign exchange rates and other costs accounted for the remainder of the increase.
In the first quarter of 2009, the Company implemented a restructuring program totaling $2.3 million, or approximately $0.14 per diluted share, while 2010 includes a net charge of $3.6 million, or $0.21 per diluted share, for the contingency noted above. The Company incurred a final charge related to the former CEOs supplemental retirement plan of approximately $1.3 million, or $0.08 per diluted share, in the third quarter of 2010, compared to a charge of $2.4 million, or $0.14 per diluted share, in the first nine months of 2009.
Other income for the 2010 period includes higher license fees from increased business activities as well as foreign exchange rate gains versus losses in the 2009 period, which partially offset a gain related to the disposition of land in Europe of approximately $0.11 per diluted share in 2009. Net interest expense decreased due to lower average debt balances as well as higher interest income.
Equity in net income of associated companies includes a charge of approximately $0.03 per diluted share related to the first quarter 2010 devaluation of the Venezuelan Bolivar Fuerte.
The Companys year-to-date 2010 effective tax rate was 26%, compared to 32% for the first nine months of 2009. The 2010 effective tax rate includes a benefit of approximately $0.15 per diluted share due to the expiration of applicable statutes of limitations
22
for uncertain tax positions. In addition, the low 2010 effective tax rate reflects significantly improved profitability in certain jurisdictions, which has allowed for the utilization of foreign tax credits and net operating losses, which were previously not benefited. The effective tax rate for the first nine months of 2009 reflects no tax provided for the land sale gain, due to the utilization of net operating losses, which were previously not benefited. The Company has experienced, and expects to experience, further volatility in its quarterly effective tax rates due to the varying timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions. The Company currently expects additional derecognition of uncertain tax positions of approximately $0.07 per diluted share to occur later in the fourth quarter of 2010. During the first nine months of 2010, the Company recorded $2.3 million of excess tax benefits in capital in excess of par on its Condensed Consolidated Balance Sheet and in its Condensed Consolidated Statement of Cash Flows, related to stock option exercises, which occurred over the current and prior years. Previously, the Companys actual taxable income in affected jurisdictions was not sufficient to recognize these benefits, while the Companys full-year 2010 projection of taxable income is expected to be sufficient to recognize these benefits. At the end of 2009, the Company had net U.S. deferred tax assets totaling $16.3 million, excluding deferred tax assets relating to additional minimum pension liabilities. The Company records valuation allowances when necessary to reduce its deferred tax assets to the amount that is more likely than not to be realized. The Company considers future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for a valuation allowance. However, in the event the Company were to determine that it would not be able to realize all or part of its net deferred tax assets in the future, an adjustment to the deferred tax assets would be a non-cash charge to income in the period such determination was made, which could have a material adverse impact on the Companys financial statements. The global economic downturn has been negatively impacting profitability in certain taxing jurisdictions. The Company continues to closely monitor this situation as it relates to its net deferred tax assets and the assessment of valuation allowances. The Company is continuing to evaluate alternatives that could positively impact taxable income in these jurisdictions.
Segment Reviews Comparison of the First Nine Months of 2010 with the First Nine Months of 2009
Metalworking Process Chemicals
Metalworking Process Chemicals consists of industrial process fluids for various heavy industrial and manufacturing applications and represented approximately 94% of the Companys net sales in the first nine months of 2010. Net sales were up $82.6 million, or 28%, compared to the first nine months of 2009. Foreign currency translation positively impacted net sales by approximately 2%, driven by the Brazilian Real to U.S. Dollar exchange rate. The average U.S. Dollar to Brazilian Real exchange rate was 0.56 in the first nine months of 2010 compared to 0.48 in the first nine months of 2009. Net sales were positively impacted by increases of 16% in North America, 25% in Europe, 35% in Asia/Pacific and 40% in South America, all on a constant currency basis. The increase in this segments sales was primarily attributable to increased volumes of 31% impacting all regions, as the prior year results continue to reflect the global economic downturn. The product volume increases were partially offset by a reduction in automotive CMS revenue, which was due, in part, to the renegotiation of certain contracts now reported on a pass-through versus gross basis. Consistent with the significant volume increases, this segments operating income increased $28.1 million over the first nine months of 2009. This segments operating income also benefited from savings from the Companys restructuring efforts as well as a more favorable year-to-date raw material cost environment.
Coatings
The Companys coatings segment, which represented approximately 6% of the Companys net sales in the first nine months of 2010, contains products that provide temporary and permanent coatings for metal and concrete products and chemical milling maskants. Net sales for this segment were down $0.4 million, or 1%, for the first nine months of 2010 compared to the first nine months of 2009, primarily due to reduced volumes in temporary and permanent coatings. This segments operating income was down $0.5 million related to the noted volume declines, product mix, as well as increased selling costs.
Other Chemical Products
Other Chemical Products, which represented less than 1% of the Companys net sales for the first nine months of 2010, consists of sulfur removal products for industrial gas streams sold by the Companys Q2 Technologies joint venture. Net sales for the first nine months of 2010 were flat with the first nine months of 2009 and operating income was a slight loss in both periods due to the downturn in the oil and gas markets.
Factors that May Affect Our Future Results
(Cautionary Statements Under the Private Securities Litigation Reform Act of 1995)
Certain information included in this Report and other materials filed or to be filed by Quaker with the SEC (as well as information included in oral statements or other written statements made or to be made by us) contain or may contain forward-looking
23
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on our current expectations about future events. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance and business, including:
| statements relating to our business strategy; |
| our current and future results and plans; and |
| statements that include the words may, could, should, would, believe, expect, anticipate, estimate, intend, plan or similar expressions. |
Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. From time to time, forward-looking statements are also included in Quakers other periodic reports on Forms 10-K, 10-Q and 8-K, as well as in press releases and other materials released to, or statements made to, the public.
Any or all of the forward-looking statements in this Report and in any other public statements we make may turn out to be wrong. This can occur as a result of inaccurate assumptions or as a consequence of known or unknown risks and uncertainties. Many factors discussed in this Report will be important in determining our future performance. Consequently, actual results may differ materially from those that might be anticipated from our forward-looking statements.
We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in Quakers subsequent reports on Forms 10-K, 10-Q and 8-K should be consulted. These forward-looking statements are subject to risks, uncertainties and assumptions about us and our operations that are subject to change based on various important factors, some of which are beyond our control. A major risk is that the Companys demand is largely derived from the demand for its customers products, which subjects the Company to uncertainties related to downturns in a customers business and unanticipated customer production planning shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, worldwide economic and political conditions, foreign currency fluctuations, and terrorist attacks such as those that occurred on September 11, 2001. Furthermore, the Company is subject to the same business cycles as those experienced by steel, automobile, aircraft, appliance, and durable goods manufacturers. These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. Other factors beyond those discussed could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
24
Item 3. | Quantitative and Qualitative Disclosures About Market Risk. |
Quaker is exposed to the impact of changes of interest rates, foreign currency fluctuations, changes in commodity prices, and credit risk.
Interest Rate Risk. Quakers exposure to market rate risk for changes in interest rates relates primarily to its short and long-term debt. Most of Quakers debt is negotiated at market rates which can be either fixed or variable. Accordingly, if interest rates rise significantly, the cost of debt to Quaker will increase. This can have an adverse effect on Quaker, depending on the extent of Quakers borrowings. As of September 30, 2010, Quaker had $40.0 million in borrowings under its credit facilities, compared to $46.4 million at December 31, 2009, at a weighted average variable borrowing rate of approximately 2.54% (LIBOR plus a spread). The Company uses derivative financial instruments primarily for purposes of hedging exposures to fluctuations in interest rates. The Company does not enter into derivative contracts for trading or speculative purposes. The Company has entered into interest rate swaps in order to fix the interest rate on a portion of its variable rate debt. The swaps had a combined notional value of $30.0 million and $40.0 million and a fair value of $(1.4) million and $(2.2) million at September 30, 2010 and December 31, 2009, respectively. As of the date of this Report, the Company is receiving a LIBOR rate and paying an average fixed rate of approximately 5% on its interest rate swaps. Three of the Companys swaps with a notional value of $15.0 million mature in 2010, while the remaining three swaps with a notional value of $15.0 million mature in 2012. The counterparties to the swaps are major financial institutions. Outstanding financial derivative instruments expose the Company to credit loss in the event of nonperformance by the counterparties to the agreements. To manage credit risk, the Company limits its exposure to any single counterparty. However, the Company does not expect any of the counterparties to fail to meet their obligations. Reference is made to the information included in Note 6 of the Notes to Condensed Consolidated Financial Statements.
Foreign Exchange Risk. A significant portion of Quakers revenues and earnings is generated by its foreign operations. These foreign operations also hold a significant portion of Quakers assets and liabilities. All such operations use the local currency as their functional currency. Accordingly, Quakers financial results are affected by risks typical of global business such as currency fluctuations, particularly between the U.S. Dollar, the Brazilian Real, the Chinese Renminbi and the E.U. Euro. As exchange rates vary, Quakers results can be materially affected.
The Company generally does not use financial instruments that expose it to significant risk involving foreign currency transactions; however, the size of non-U.S. activities has a significant impact on reported operating results and the attendant net assets. During the past three most recent fiscal years, sales by non-U.S. subsidiaries accounted for approximately 58% to 62% of consolidated net annual sales.
In addition, the Company often sources inventory among its worldwide operations. This practice can give rise to foreign exchange risk resulting from the varying cost of inventory to the receiving location as well as from the revaluation of intercompany balances. The Company mitigates this risk through local sourcing efforts.
Commodity Price Risk. Many of the raw materials used by Quaker are commodity chemicals, and, therefore, Quakers earnings can be materially adversely affected by market changes in raw material prices. In certain cases, Quaker has entered into fixed-price purchase contracts having a term of up to one year. These contracts provide for protection to Quaker if the price for the contracted raw materials rises, however, in certain limited circumstances, Quaker will not realize the benefit if such prices decline.
Credit Risk. Quaker establishes allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. If the financial condition of Quakers customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. Downturns in the overall economic climate may also tend to exacerbate specific customer financial issues. A significant portion of Quakers revenues is derived from sales to customers in the U.S. steel and automotive industries, including some of our larger customers, where a number of bankruptcies occurred during recent years and companies have experienced financial difficulties. When a bankruptcy occurs, Quaker must judge the amount of proceeds, if any, that may ultimately be received through the bankruptcy or liquidation process. In addition, as part of its terms of trade, Quaker may custom manufacture products for certain large customers and/or may ship product on a consignment basis. These practices may increase the Companys exposure should a bankruptcy occur, and may require write-down or disposal of certain inventory due to its estimated obsolescence or limited marketability. Customer returns of products or disputes may also result in similar issues related to the realizability of recorded accounts receivable or returned inventory.
25
Item 4. | Controls and Procedures. |
Evaluation of disclosure controls and procedures. As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the Exchange Act), our management, including our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our principal executive officer and our principal financial officer have concluded that as of the end of the period covered by this report our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were effective.
Changes in internal control over financial reporting. As required by Rule 13a-15(d) under the Exchange Act, our management, including our principal executive officer and principal financial officer, has evaluated our internal control over financial reporting to determine whether any changes to our internal control over financial reporting occurred during the quarter ended September 30, 2010 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Based on that evaluation, no such changes to our internal control over financial reporting occurred during the quarter ended September 30, 2010.
26
OTHER INFORMATION
Items 1, 1A, 3, 4 and 5 of Part II are inapplicable and have been omitted.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds. |
The following table sets forth information concerning shares of the Companys common stock acquired by the Company during the period covered by this report, all of which were acquired from employees in payment of the exercise price of employee stock options exercised during the period.
Issuer Purchases of Equity Securities
Period |
(a) Total Number of Shares Purchased (1) |
(b) Average Price Paid per Share (2) |
(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3) |
(d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (3) |
||||||||||||
July 1 July 31 |
| $ | | | 252,600 | |||||||||||
August 1 August 31 |
1,937 | $ | 36.32 | | 252,600 | |||||||||||
September 1 September 30 |
| $ | | | 252,600 | |||||||||||
Total |
1,937 | $ | 36.32 | | 252,600 |
(1) | All of the 1,937 shares acquired by the Company during the period covered by this report were acquired from employees upon their surrender of previously owned shares in payment of the exercise price of employee stock options. |
(2) | The price per share, in each case, represented either a) the average of the high and low price of the Companys common stock on date of exercise; or b) the closing price of the Companys common stock on date of exercise, as specified by the plan pursuant to which the applicable option was granted. |
(3) | On February 15, 1995, the Board of Directors of the Company authorized a share repurchase program authorizing the repurchase of up to 500,000 shares of Quaker common stock, and, on January 26, 2005, the Board authorized the repurchase of up to an additional 225,000 shares. Under the 1995 action of the Board, 27,600 shares may yet be purchased. Under the 2005 action of the Board, none of the shares authorized has been purchased and, accordingly, all of those shares may yet be purchased. Neither of the share repurchase authorizations has an expiration date. |
27
Item 6. | Exhibits. |
(a) Exhibits
31.1 | - | Certification of Chief Executive Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 | ||
31.2 | - | Certification of Chief Financial Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 | ||
32.1 | - | Certification of Michael F. Barry Pursuant to 18 U.S. C. Section 1350 | ||
32.2 | - | Certification of Mark A. Featherstone Pursuant to 18 U.S. C. Section 1350 |
*********
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
QUAKER CHEMICAL CORPORATION |
(Registrant) |
/s/ Mark A. Featherstone |
Mark A. Featherstone, officer duly authorized to sign this report, Vice President and Chief Financial Officer |
Date: October 26, 2010
28